- Time schedule in France & Germany : 10:15 to 12:15
- Time schedule in Japan : 18:15 to 20:15
AI technologies offer the potential to improve health care activities (precision of diagnosis, drug development, personalised medicine, and relationships between treatment techniques and patient outcomes, etc.), but also raise concerns about data-sharing and data protection issues, as well as ethical issues more generally.
Moreover, as the populations of Japan, Germany and France are aging, our societies will have to offer services (not only care) to an unprecedented number of seniors.
This session will discuss how health care, nursing and services can be improved by leveraging AI models in the context of an aging society.
What advantages could Japan, France and Germany derive from working together (i.e. scientists, companies, political decision-makers, etc.) on this topic? Why? How can we improve co-operation and what are the current brakes and deadlocks?